Surgery Partners, Inc. Announces Third Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Jefferies Cuts Price Target on Surgery Partners, Inc. (SGRY) to $24 Following 3Q
November 10, 2016 10:19 AM ESTJefferies maintained a Buy rating on Surgery Partners, Inc. (NASDAQ: SGRY), and cut the price target to $24.00 (from $27.00), following the company's 3Q earnings report. SGRY put up strong SS rev growth of +10.3% in Q3, which highlights the company's ability to continue driving consistent, double-digit... More
Surgery Partners (SGRY) Tops Q3 EPS by 7c
November 9, 2016 5:13 PM ESTSurgery Partners (NASDAQ: SGRY) reported Q3 EPS of $0.21, $0.07 better than the analyst estimate of $0.14. Revenue for the quarter came in at $282.7 million versus the consensus estimate of $283.8 million.
Same-facility revenue increased 10.3% over third quarter 2015 to $281.2 million.
For earnings history and earnings-related data on Surgery Partners (SGRY) click here.
... More